Inhaled insulin and insulin antibodies: A new twist to an old debate

Diabetes Technology and Therapeutics

Volumn 4, Issue 2, 2002, Pages 157-161

  Stoever, James A ^a   Palmer, Jerry P ^a  

^a Puget Sound Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE INSULIN; GLUCOSE; HUMAN INSULIN; INSULIN; INSULIN ANTIBODY; PIG INSULIN; RECOMBINANT HUMAN INSULIN;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG HALF LIFE; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INSULIN TREATMENT; INTESTINE LYMPHATIC TISSUE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; BLOOD; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, INHALATION; DIABETES MELLITUS; HUMANS; INSULIN; INSULIN ANTIBODIES;

EID: 0035998734     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/15209150260007372     Document Type: Article

References (35)

1. Insulin human insulin treatment in patients with type 2 diabetes mellitus
2. Efficacy of inhaled human insulin in type 1 diabetes mellitus: A randomised proof-of-concept study
3. Efficacy and safety of inhaled insulin (Exubera) compared to subcutaneous insulin therapy in patients with type 2 diabetes: Results of a 6-month, randomized, comparative trial
4. Insulin autoantibodies at diagnosis of insulin-dependent diabetes: Effect on the antibody response to insulin treatment
5. Effects of species of origin, purification levels, and formulation on insulin immunogenicity
6. Insulin antibodies induced by bovine insulin therapy
7. Insulin antibodies in non-insulin-dependent diabetes mellitus: Effect of treatment with semisynthetic insulin
8. Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment
9. Immunogenicity of long-term intraperitoneal insulin administration with implantable programmable pumps
10. Insulin antibodies do not influence the absorption rate of subcutaneous injected insulin
11. Prolonged action of regular insulin in diabetes patients: Lack of relationship to circulating insulin antibodies
12. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus
13. Effect of insulin antibodies on insulin pharmokinetics and glucose utilization in insulin-dependent diabetic patients
14. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics
15. Insulin autoimmunity in a case of spontaneous hypoglycemia
16. Prolonged fasting hypoglycemia due to insulin antibodies in patients with non-insulin-dependent diabetes mellitus: Effect of insulin withdrawl on insulin-antibody-binding kinetics
17. Hyperglycemia, hypoglycemic attacks, and production of anti-insulin antibodies without previous known immunization
18. Hypoglycemia due to apparent autoantibodies to insulin
19. Mechanism of hypoglycemia observed in a patient with insulin autoimmune syndrome
20. A new type of hypoglycemia in a newborn infant
21. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up
22. Immunogenicity of monocomponent human and porcine insulin in newly diagnosed type 1 (insulin-dependent) diabetic children
23. The effect of insulin antibodies on insulin dose and diabetic control
24. Metabolically inactive insulin analog prevents type 1 diabetes in prediabetic NOD mice
25. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice
26. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific c DNA library
27. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy
28. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes prone animals
29. Takahashi: Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes
30. Induction of insulitis in BALB/c mice
31. Potential risk of oral insulin with adjuvant for the prevention of type 1 diabetes: A protocol effective in NOD mice may exacerbate disease in BB rats
32. Cellular immune responses to human islet protein in antibody-positive type 2 diabetic patients
33. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
34. Bronchus-associated lymphoid tissue (BALT) is not present in the normal lung but in different diseases